Intervet / Schering-Plough Animal Health has announced that Optimmune - which is used to treat Keratoconjunctivitis sicca (KCS) in dogs - is back in stock three weeks ahead of schedule following a temporary shortage in January.
Melanie Dass, product manager at Intervet / Schering-Plough Animal Health said: "We were aware that the shortage would happen so took steps to manage the supplies that were available and to resume production as soon as possible.
"We wrote to all our veterinary customers informing them of the likely shortage and fortunately, as a result of doing everything we could to minimise disruption, the product is now back three weeks earlier than expected and we are confident in our long term supply."
Melanie added: "We will be allocating stock in February to ensure all practices receive enough product to meet the needs of clinical cases, which amounts to approximately 125% of average monthly usage. This should allow a smooth return to normal deliveries in March.
"We would like to thank all our veterinary customers for helping us manage the allocation of the product and for their understanding during this difficult situation."
Any practices that require additional stock for clinical cases during February, should contact their Intervet / Schering-Plough account manager or the Veterinary Support Group on 01908 685685.
National charity Canine Partners, which provide specially trained assistance dogs to people with disabilities, will benefit from an Eastbourne vet's efforts to run the Brighton Marathon on Sunday 10th April in less than 3.5 hours.
Simon DeVile is undertaking a gruelling training scheme, covering up to 50 miles a week, to ensure peak performance when he takes to the streets to raise money for Canine Partners - a charity close to his heart.Simon, 44, is one of the partners at St. Anne's Veterinary Group in Eastbourne. He started running to keep fit in 2006 and has since run the London Marathon twice and the Beachy Head Marathon three times. Simon regularly comes into contact with canine partner puppies because a local fundraiser and puppy parent is one of his clients. His own dog is also part of a locally bred litter, five of which went on to train as canine partners.Simon said: "I wanted to enjoy a new marathon experience this Spring and Brighton proved very popular last year. My aim is to enjoy the race but hopefully get below 3hrs 30 mins and raise money for Canine Partners. I am very aware what an important role these dogs play in the lives of a person with disabilities. I am also continually impressed with the way Canine Partners look after the dogs in their care so well."
If you would like to support Simon's efforts, visit: http://www.justgiving.com/Simon-DeVileCanine Partners still has charity places available for The Brighton Marathon. If you would like to take up the challenge, please contact Jill Green on 01730 716014.
MSD Animal Health has launched FlockCheck 2012, its complimentary sheep diagnostic service that identifies whether enzootic abortion or toxoplasmosis is present in a client's flock.
FlockCheck 2012 requires vets to take blood samples from 6-8 aborting ewes. MSD says that at a time when many farmers are asking for veterinary diagnostic support to confirm or rule out potential Schmallenberg virus infection, it makes sense to investigate whether other diseases are present in the flock at the same time.
MSD Animal Health ruminant veterinary adviser Drew McGurren MRCVS said: "Based on the previous two years' FlockCheck data (2011 and 2010), on average over 86% of submitted samples tested positive for toxoplasmosis and more than 62% were positive for enzootic abortion. Around 43% of samples showed exposure to both diseases.
"With lamb prices still remaining buoyant it has never been more important to ensure farmers minimise lamb losses. The 2012 FlockCheck service allows vets to identify whether toxoplasmosis or enzootic abortion is the cause of any aborted lamb losses and provides a starting point for discussions around the value of vaccination programmes with Enzovax and Toxovax."
Vets are asked to submit unit blood samples with the new 2012 FlockCheck forms.
The nominations allow practices to recognise someone at their workplace who has helped to hold up morale during a time when practices are facing unprecedented staffing and financial issues, and have taken it upon themselves to foster a positive work environment.
The Practice Wellbeing Star nominations were originally launched to accompany the Practice Wellbeing Awards, which have been cancelled this year because of the pandemic.
Liz Barton, SPVS representative on the Mind Matters Taskforce (pictured right), said: “With great regret we have had to postpone the Practice Wellbeing Awards as we recognise that practices may neither have the time nor resources right now to go through our comprehensive application process. However, there is still definitely a place for recognising those individuals who are going above-and-beyond to help their colleagues navigate their way through these difficult times.
"Nominating a team member is a great opportunity to discuss with your team and reflect on the positive things that are happening, and to nominate one person who has been particularly invested in contributing to creating positive team culture.
"The Practice Wellbeing Star nominations are open to all veterinary practices, and teams, including those working in universities, industry and business.
“We look forward to receiving your nominations and celebrating exceptional individuals who are committed to improving the mental health and wellbeing of their colleagues.”
Members of the veterinary team who are nominated for as a Practice Wellbeing Star will receive a certificate in recognition of their colleagues’ appreciation of their achievements.
Recipients of the certificate will also be entered into the prize draw for a pair of tickets to attend the joint SPVS and Veterinary Management Group Congress in January 2021.
Further information on how to nominate is on the Vet Wellbeing Award website at: vetwellbeingawards.org.uk/practice-wellbeing-star/
The closing date for Practice Wellbeing Star nominations is Friday 20 November 2020.
For those new to the club, the idea is that every two weeks, we pick an article in Veterinary Practice and invite the author to join us on VetSurgeon.org, so that you can ask questions and discuss the subject with one another.
As a bonus, you can claim time spent reading or participating in the discussion towards your annual CPD requirement (press the claim CPD button at the top right of the discussion thread).
For this first discussion of 2023, author Andy Yale, an RCVS and European Veterinary Specialist in Small Animal Oncology and Lecturer in Veterinary Oncology at the RVC, will be joining us for a week to answer questions about 'Diagnosis and treatment of common canine oral tumours'.
To take part, first read Andy's article here: https://www.veterinary-practice.com/article/common-canine-oral-tumours.
Then come and join the VetSurgeon Clinical Article Club and post your questions or discussion points here: https://www.vetsurgeon.org/associations/vetsurgeon-clinical-article-club/
VetSurgeon.org Editor, Arlo Guthrie said: "I hope lots of you will come and join in. It really is a great opportunity to learn from specialists and from each other in a professional, moderated forum, where you can be confident of a friendly welcome.”
To find out about the RVC’s internationally recognised veterinary oncology team and the services it offers, visit: https://www.rvc.ac.uk/small-animal-vet/specialist-referrals/clinical-services/veterinary-oncology
CVS says the use of ear cytology in OE is beneficial, both as a diagnostic and to evaluate the response to therapy.
However, in 2019 the company looked at 26,269 of its patients and found that ear cytology was only being used in 19.2% of cases, in line with the rest of the profession.
Only 11% of cases were being provided with in-house point-of-care cytology, whilst 8.2% had it performed externally.
80.8% of patients with OE were being prescribed antibiotics without cytological support, with 5% of these the highest priority critically important antibiotics (HPCIAs).
This low level of cytology use in primary care was suspected to be a major contributory factor to the significant use of unnecessary antibiotics.
To support its practices, CVS first looked at the barriers to performing ear cytology interventions, which were identified as a lack of confidence in using the microscope (particularly focusing on x100 and identification of pathological events), a perceived lack of time, insufficient or poorly working equipment, a lack of access to equipment, and the perception that cytology does not change the treatment choice or outcome.
As a second step, a minimal list of cytology equipment was developed to ensure that all sites had the right kit.
New equipment was then supplied to a practice if it did not meet minimum standards.
The company then produced education and resource materials, including new guidelines, imagery and video guides, to upskill both its vets and nurses.
The training focused on: equipment maintenance, cleaning and troubleshooting, how to use the microscope – including x100 magnification and the slide oil immersion technique, how to identify pathological changes, and time management to get a consultation done – including swabbing, microscope analysis, diagnosis and client consultation.
Each site was then provided with its own data, so that it could monitor progress.
Elizabeth McLennan Green, CVS Clinical Director for the North, said: “One of our goals with this project was to minimise the number of antibiotics prescribed without associated diagnostics, and to use ear cytology to guide therapy and response to treatment for the benefit of our patients and clients.”
“We know that low ear cytology interventions are an issue across the profession. We wanted to do better. So ear cytology has been our first and longest running clinical improvement project.
"We’re thrilled with the brilliant results our colleagues are now achieving.”
There's a video presentation about the project here: https://vimeo.com/875515008/bdc3ee5920
Photo: Emily Spencer, Head Vet at Castle Vets
Dan Forster MRCVS and his wife Kirsty, a veterinary nurse, run The Mobile Vet Ltd, which offers a 24/7 mobile service to clients and their animals on the Isle of Wight. The team work out of custom-designed vehicles, as well as their fully equipped static veterinary clinic in Newport.
In launching The Mobile Vet, their vision was to create a mobile clinic which could provide all of the services normally provided in a traditional clinic rather than just some. The veterinary team uses the latest technology and veterinary software to communicate with clients and works from vehicles specifically designed by Dan and Kirsty.
The Queen’s Awards for Enterprise are awarded to businesses for outstanding achievement in International Trade, Innovation and Sustainable Development. Winners of the Innovation Awards are judged to have shown outstanding success as the result of an innovation.
Dan said: "We aim to offer a caring and professional service to Islanders and their pets while also maintaining a good work/life balance. We can do almost everything from our vehicles but, when necessary, we utilise our fully equipped static clinic. We aim to offer a highly professional veterinary service using state-of-the-art equipment, which is also convenient to our clients. We have recently introduced a CT scanning service and laparoscopic surgery to expand our clinical services further.
"We are honoured to receive this prestigious award and had a fantastic day. The Award would never have been achievable without the support of our wonderful team. We look forward to continuing to provide an exemplary level of service to our clients."
The original TATE elbow replacement was first in clinical use in the 2010s and the revised 3rd generation version is apparently a much-improved implant, something which the clinical evaluation trial should demonstrate.
Andy Moores, head of the joint replacement programme at The Moores Orthopaedic Clinic, said: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain but up until this point the elbow replacement systems have not been as reliable as we would like.
"The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising.
"We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this.
"We look forward to offering this surgery as an option for some of our most painful canine patients.”
www.mooresortho.com
The RCVS and the BVA have announced the launch of Vet Futures, a jointly funded initiative designed to stimulate discussion about the future of the profession, and help its members prepare for and shape it.
The initiative will draw on the experience and insight of a wide range of individuals and organisations, including veterinary surgeons and nurses, veterinary bodies, farmers, pet owners and other key stakeholders.
The objective is to understand where the provision of veterinary services is currently heading, whether this is in the best interests of the profession, animal owners and the public at large, and what might be done to shape an optimal future for the veterinary team, keeping animal health and welfare at its heart.
In the project's first phase, independent researchers will gather evidence via focus groups, phone interviews and desk-based research, in addition to the gauging of opinion through events, the internet and social media.
This evidence gathering will be followed by an engagement phase, where the profession will be asked for their feedback on initial thoughts; a period of analysis, where a report will be written by the independent researchers; and, finally, there will be an action phase, where key strategic issues will be identified, together with a clear plan for action from the BVA and the RCVS, as well as other organisations and individuals.
Professor Stuart Reid, RCVS President. said: "The RCVS is implementing a programme of reform to make it a first-rate regulator, but how do we also make ours a first-rate profession, that is resilient and agile enough to meet future demands?
"The Vet Futures project will not just be about horizon-scanning, but getting a fix on those issues over the horizon that we may not yet have considered, such as the use of emerging technologies.
"It's an exciting challenge and I am looking forward to members of the veterinary team getting involved so that, together, we can develop an action plan that will deliver a sustainable future for the profession."
John Blackwell, BVA President, said: "It is no secret that the veterinary profession is changing rapidly and that is why the theme for my presidential year is 'driving change and shaping the future'. It is essential that we come together to map out where we want to be as a strong and trusted profession and identify how we can make that happen.
"On such cross-cutting issues it is appropriate that the two leading professional bodies come together to provide joint leadership for the profession, but we are keen to engage as many individuals and stakeholders as possible. It is designed to be a hugely collaborative project and we want to hear voices from across the whole profession and the whole veterinary team."
The project has a dedicated website www.vetfutures.org.uk where the latest events, reports and publications will be found. There will also be a 'topic of the month' for the duration of the project, with controversial opinion-pieces being posted to stimulate debate from within the profession and amongst animal owners and other stakeholders.
Hand-mouldable into any shape, Hoof Repair is used to create prosthetic hoof extensions and additions that restore foot integrity.
The company says there is no exothermic reaction when the thermoplastic hardens, which eliminates issues caused by excessive heat and makes the product suitable for treating acute laminitis, cracked hooves and horses that have lost a lot of hoof.
When used with Imprint Structural Adhesive, Hoof Repair forms a bond with hoof wall which can be nailed into and rasped, and will stay in place as hoof grows. Hoof Repair is also suitable for treating foal foot deformities.
The company says Hoof Repair is often used in conjunction with Imprint shoes, which are made of the same low melt, long lasting thermoplastic. It allows extensions to be made to the shoes and together the Imprint system protects and supports the hoof allowing the foot to flex and move freely.
Andrew Poynton, Imprint’s Inventor said: "Hoof Repair forms part of a foot care system that has been developed over 20 years by farriers in association with veterinary surgeons. Hoof Repair assimilates hooves precisely to retain the foot integrity and it is particularly useful for treating acute laminitis and cracked or badly damaged hooves."
Ceva Animal Health has launched two iPhone Apps for veterinary professionals and cat owners.
The 'Metoclopramide' iPhone App calculates both the daily fluid requirements and the volume of metoclopramide to add to the fluid bag for a dehydrated, vomiting cat or dog.
The 'Cat Stress' App helps pet owners to measure the stress levels of cats by asking questions about their home environment; this will help evaluate the effect that modern living has on feline stress levels which may, in turn, encourage owners to take action to help prevent cats developing stress related behavioural or medical problems in later life.
The 'Metoclopramide' iPhone App is available to download from the iTunes store here.
The 'Cat Stress' iPhone Apps is available to download from the iTunes store by searching for 'Cat Stress'.
For further information, please contact your Ceva Animal Health representative or call the veterinary support team on 01494 781510.
Axiom Veterinary Laboratories and Woodley Equipment Company have announced a partnership which the companies say will mean they can offer a comprehensive solution encompassing referral laboratory services and in-house diagnostic testing, with significant cost savings for practices.
Steve Clarke, Business Development and Marketing Manager for Axiom said: "After an exhaustive search we believe that we have found a partner in Woodley that shares our drive and ambition in delivering a first class solution to practices along with service backup. We offer a cost-effective, quality service with flexibility, fast turnaround times including a free of charge courier service across many parts of the UK and Ireland. We believe that in the current economic climate it is an ideal time for practices to review both their referral laboratory service and their in-house equipment provision."
Mike Wickham, Managing Director of Woodley Equipment Company added: "We offer a wide range of equipment, tailored to the size of the practice, workload and specialty. In partnering with Axiom Veterinary Laboratories we are able to offer a complete package including exclusive and very competitive discount structures for practices.
Both companies with be exhibiting at the forthcoming WSAVA conference in Birmingham (Axiom stand 418 and Woodley Equipment Company stand 718).
Zoetis has announced that a batch of the bluetongue vaccines, Zulvac® 8 Bovis and Zulvac® 8 Ovis, is expected to become available to veterinary practices in mid-July, in time to manage the risk of an outbreak predicted by Defra to reach mainland UK by the late summer.
The company says the quantity of vaccine will not be unlimited and that it will strive to achieve as widespread availability as possible.
The two vaccines (Bovis for cattle and Ovis for sheep) are licensed to “prevent viraemia” caused by bluetongue virus serotype 8 (BTV-8). Prevention of viraemia, the presence of bluetongue virus in the blood, ensures no onward spread of infection via the blood sucking Culicoides midge.
The vaccines can be used in cattle from three months of age, or six weeks in sheep, requiring two doses three weeks apart in either species. Each dose is 2ml administered intramuscularly in cattle or subcutaneously in sheep, and onset of immunity is 25 days after the second dose. The vaccine provides immunity for a full 12 months.
The British Veterinary Association (BVA), British Cattle Veterinary Association (BCVA), Goat Veterinary Society (GVS), and Sheep Veterinary Society (SVS) welcomed the announcement from Zoetis, and another from MSD, but sought clarification about the cost and the amount of vaccine likely to be available in July and thereafter.
BVA President Sean Wensley said: "We welcome the announcement that vaccine will be available in time to meet potential demand. This disease seriously affects animal health and welfare as well as the productivity of livestock, and vaccination is the key control. While it is good news that vaccine will be available, we know that both farmers and vets will have questions about cost and whether there will a limit to the amount of vaccine available in July. It would be helpful to have these questions clarified as soon as possible."
Photo by Fourrure (http://www.boulesdefourrure.fr) [CC BY-SA 2.0], via Wikimedia Commons
The programme covers everything from diagnostic imaging and ophthalmic emergencies to using echocardiography to help with day-to-day decision-making in practice.
SCVS says the programme has been made possible by the addition of a new lecture theatre during SCVS’s recent expansion, which was supported by the hospital's owners IVC Evidensia.
Stephen Collins, SCVS Hospital Director and IVC Evidensia’s National Cardiology Lead, said: “We’re proud to announce one of the UK’s most comprehensive CPD programmes and share the vast knowledge that our specialist team has with the rest of the veterinary community.
“Our programme is packed full of informative and practical sessions that every vet can benefit from - whether that’s specialist skill development or improving everyday advice and practices in clinic.”
A full list of CPD events is available here: https://www.ivcevidensiareferrals.com/events-and-cpd.
www.scvetspecialists.co.uk
The five-minute survey includes questions on the number of otitis externa cases seen in practice, consultation times, common compliance issues, cytology uptake and client behaviour change frameworks.
Completed entries will be entered into a draw for a Fortnum & Mason hamper worth £100.
Charlotte Hill, brand manager at Dechra said: “The otitis externa in dogs survey will provide us with valuable insight into vets’ experiences of the condition.
"It will also allow us to identify any trends that may exist to help us improve how we as a profession approach otitis externa, while supporting owners when treating the condition which can be frustrating to manage.
https://forms.office.com/e/J7frrbL56A
Ceva Animal Health has launched Vectra 3D, a broad spectrum topical ectoparasiticide for dogs which is effective against fleas, ticks and flies.
Vectra 3D contains a formulation of a brand new active called dinotefuran, pyriproxyfen and permethrin.
According to the company, Vectra 3D provides a rapid flea kill within two hours for dogs on current treatment and complete protection against the major vectors: fleas, ticks, sand flies, mosquitoes and stable flies1. Additionally, because dinotefuran kills on contact, it is claimed to reduce the incidence of flea feeding1.
Vectra 3D is applied in a line from the base of the tail to the neck using a patented applicator with an elongated tip, designed to make it easy to apply the product through the hair directly onto the skin. The applicator is also designed to provide accurate dosing without making any mess, as nothing comes out until the tube is squeezed.
Ceva highlights that the number of people travelling with their pets has increased by 61% since 20122, and that Vectra 3D is the only topical ectoparasiticide that offers repellent action against sand flies for one month, together with protection against mosquitoes and stable flies.
Julia Wood, product manager at Ceva Animal Health said: "Vectra 3D is an innovative formulation which uses a unique, easy-to-administer applicator to provide complete protection against fleas, ticks and flies. And with spring nearly upon us, it's time to start talking to clients about flea treatments, such as Vectra 3D."
To support the launch of Vectra 3D, Ceva is hosting a series of CPD meetings at venues across the UK. Accounting for two hours CPD, the afternoon meetings will cover vector-borne diseases, the importance of ticks in the UK and product information on Vectra 3D. They will be presented by Ian Wright BVMS BSc MSc MRCVS and Richard Wall BSc MBA PhD FRES and take place at:
For further information, contact your Ceva Animal Health territory manager or email Ceva Animal Health on customerservicesuk@ceva.com.
The Vet Futures Action Plan included a series of 24 work-streams to be completed over five years (2016-2020), building on the six core themes of: animal health and welfare; veterinary professionals’ wider roles in society; the health and wellbeing of veterinary professionals; diverse and rewarding veterinary careers; sustainable businesses and user-focused services; and leadership.
Vet Futures reports that over the last twelve months, key activities have included:
VN Futures
The VN Futures project (Action X of Vet Futures) isolated six ambitions to achieve by 2020, with the shorter time-scale reflecting the faster rate of both turnover and training for veterinary nurses.
A number of development groups have been created, focusing on each of these ambitions and creating specific actions to ensure their completion. Of these:
RCVS President, Chris Tufnell said: "When we launched Vet Futures back in 2014, the scope of the project seemed daunting and some were sceptical of our ability to succeed. However, through a robust process of evidence-gathering, analysis, action planning and now taking action itself, we are starting to make an impact on some of those core areas that are so fundamental to the future of our profession, such as animal welfare, technology, veterinary skills and knowledge, and leadership.
"Our Action Plan set out a five-year timeframe and we have made some really excellent progress in year one. This will form the foundation of work yet to come – although it remains important to ensure we scan the horizon for new issues that will have an impact on the profession, navigating our way through challenges as they arise."
BVA President Gudrun Ravetz added: "The excitement was palpable at the Vet Futures Summit last year and it spurred us on to roll up our sleeves immediately to start working on the Action Plan, and so a lot has been achieved already.
"Many of the actions are interlinked and so BVA, RCVS and the VSC are working closely together to oversee their delivery, but we have been particularly pleased at the high level of engagement and enthusiasm from others. The success of Vet Futures will be in the profession coming together to bring about the changes we need for a sustainable future.”
The course has been made available after its authors, Dr Katherine Wakelin and Sarah Corthorne from the University of Surrey, received a Mind Matters Grant to conduct research which found it improved the mental wellbeing of veterinary professionals.
Katherine and Sarah will also be hosting a webinar from 7pm – 8pm on Tuesday 3rd September to discuss the importance of self-compassion, provide an overview of their research, as well as information on the course itself.
Katherine said: “Our recent randomised control trial has shown the course to significantly improve resilience and self-compassion and reduce rumination and self-criticism amongst veterinarians.
"Therefore, Sarah and I are delighted to now be disseminating the CFT course freely to the veterinary profession, so that as many people as possible are able to benefit from the evidence-based resource.
“Even though our research was conducted on veterinary surgeons, we hope that the course will be useful to all those working in the veterinary team as the content can be applied in a number of contexts.
“Our webinar will explain more about our research, as well as some of the science behind the effectiveness of the course in a veterinary context.
"So, if you are interested in learning more about how CFT may be able to help you and your team, both in a personal and professional capacity, please do come along.”
In order to access the online compassion course, individuals are invited to complete a short questionnaire before and after watching one video (10-15 minutes long) each day for 14 days. The aim of the video intervention is to develop self-compassion skills and reduce self-criticism. This will also allow Katherine and Sarah to evaluate the ongoing impact that the videos are having on those working in the sector.
https://vetmindmatters.org/resources/free-online-compassion-course-for-veterinarian-mental-wellbeing/
Inocul8 and the Global Alliance for Livestock Veterinary Medicines (GALVmed), have launched vetvac.org a free new online database of information about livestock and poultry vaccines.
Currently the Vetvac database contains information on nearly 2,000 livestock vaccine products produced by more than 95 manufacturers. This included cattle, sheep, goat, pig and poultry vaccines available in the UK, Australia, Africa, India, South America and the United States. It is being expanded and updated on a continuous basis, and aims to cover all markets, providing the most complete compendium of licensed livestock vaccine products available worldwide.
The database developers say that they hope Vetvac.org will be especially useful to vaccine manufacturers and developers, and animal health professionals and livestock keepers.
Josef Geoola, Vetvac's co-founder, said: "Although there are a number of on-line databases and websites that focus on livestock vaccines, none provide the global coverage that Vetvac.org aims to achieve - our product will be unique."
A survey conducted earlier this year by Novartis Animal Health1 has shown that owners of dogs diagnosed with atopic dermatitis want to learn more about the condition after their veterinary consultation.
When asked about what would help them understand and cope with their dog receiving a diagnosis of atopic dermatitis, 42% of dog owners said that they want reliable information about the condition on the Internet that they can read at their own pace. 27% said that hearing or reading about case studies of dogs that were diagnosed with atopic dermatitis would be a source of help and reassurance.
That isn't to take anything away from the importance of the relationship between owner and vet: 49% of respondents said that having enough time to discuss everything with their vet is the most important thing following a diagnosis of atopic dermatitis.
However, the reality of busy small animal practice means that some vets are apparently finding themselves short of time, with 62% saying that they would like to have more time in consultations to explain the diagnosis fully.
To support both vets and owners, Novartis has produced a range of education materials available at www.itchfreepet.co.uk. They include information about a variety of skin conditions in dogs and cats, including causes, clinical signs, diagnostics and treatment options, which can all be used to support recommendations made during consultations.
Novartis says it is also continuing to support vets with the 'Comfort Club' scheme, through which owners get the 2nd, 6th and 12th month of Atopica treatment free of charge. The club also allows clients to try other dermatology products that might help their pet's condition free of charge, including shampoo, EFA's and specialist diets.
Ricardo Garvao, category manager at Novartis said: "By providing reliable information and tools to help re-iterate and expand on the information given to owners by their vets, we hope to help both parties make the most of the face to face time that they have with each other. Ultimately this will strengthen the vet-client relationship, which can only improve long-term clinical outcomes.
"Good client education is vital, demonstrated by the fact that nearly a quarter (23 per cent) of pet owners that admit to giving up on their vet's advice claim that this is because they haven't understood it. A large part of the trust building process is being able to recommend a management strategy with proven efficacy and safety data for long-term use, such as Atopica. Atopica has been keeping dogs with atopic dermatitis comfortable for a decade due to its proven ability to safely provide long-term reduction of pruritus and skin lesions associated with the disease, as demonstrated by the recently published independent paper 'The use of ciclosporin: a decade of experience in veterinary dermatology."
Reference
Eukanuba's Longevity Council has published a new video in which the panel of experts offer their thoughts about how veterinary surgeons can educate clients about helping their pets grow old gracefully.
The video includes contributions from the following council members, discussing things like preventative medicine and the importance of good diet/body weight and exercise:
watch?v=JRjCWhnGaGY
The webinar will allow veterinary teams to learn from three expert speakers how they can make small practical changes to have positive impacts in their own settings.
Helen Ballantyne, Chair of the UK One Health Coordination Group (UKOHCG) and both a human and animal health nurse, will provide a ‘human’ view of One Health and the strategies in the NHS.
She will highlight areas of excellent practice she has experienced, and from a One Health angle where the veterinary profession could learn from the NHS, and vice versa.
Fergus Allerton MRCVS, an Internal Medicine Specialist and lead on antimicrobial resistance (AMR) at Linnaeus will talk about, amongst other things, the optimal use of antimicrobials for infection control.
In collaboration with the NHS, he launched Veterinary Antibiotic Amnesty activity which saw a 19% reduction of antimicrobial use across the Linnaeus veterinary group.
Fergus will also talk about the PROTECT ME guidelines on the responsible use of antibacterials, such as for surgical antibiotic prophylaxis.
Simon Doherty, past-president of the British Veterinary Association and one of two BVA representatives at the Federation of Veterinarians in Europe, will focus on the history of One Health and One Agriculture; highlighting how improved communication and collaboration at the intersection of people, animals and the environment can drive productivity and sustainability in food production.
Simon will also share some of Vet Sustain’s farm animal resources and how the principles can be applied.
To register, visit: https://horiba.link/one-health-webinar
Vets should now consider Angiostrongylus vasorum a countrywide parasite and not one that is restricted to the traditional hotspots of the South East, the Midlands and south Wales. This was the main message delivered by Shelia Brennan of University College Dublin to almost 300 vets attending the recent Bayer-sponsored A vasorum CPD meetings, held across the north of England and Scotland.
Sheila said: "Until recently, angiostrongylosis was only recognised in limited areas of the UK, and confirmed cases were few and far between. Now we are hearing reports of the disease as far afield as Kent and Glasgow and dogs are dying as a result. If caught early enough, the disease can be treated successfully. Vets should be aware of the many and varied symptoms and consider this parasite as a differential in any dog with suspicious clinical signs."
Dogs of any age can be infected with the parasite, but the majority presenting with clinical disease are less than two years of age. A number of clinical presentations are recognised. Dogs may present with respiratory signs (cough, exercise intolerance), coagulopathy, neurological signs, syncope and in a small number of cases hypercalcaemia. These signs can occur in isolation or in combination, and not all dogs have respiratory signs. Haemorrhage following routine neutering has been anecdotally reported. Dogs with a history of eating the parasite's intermediate hosts (slugs and snails) should be considered as being at high risk.
Chris White, Bayer's Advocate product manager said: "The attendance of nearly 300 vets at the four-meeting series, in areas not normally associated with the disease, is further evidence that vets are becoming increasingly concerned about the threat posed by A vasorum. This is the third series of meetings we have held, reaching around 1,000 vets and vet nurses across the country."
The RCVS has released the results of a competition held at BSAVA Congress earlier this month, in which veterinary surgeons, veterinary nurses and other members of the practice team were asked to identify three animals from sound only.
The correct answers were a purring cat, a Chihuahua dog (the breed had to be specified) and a guinea pig.
Of 370 entrants, only 104 (28%) were correct. Some of the more outlandish answers included, for the cat noise: elephant, lion, whale and dolphin; and, for the guinea pig noise: ferret, meerkat, dove, chicken and frog. However, the majority of those getting it wrong were stumped by the requirement to specify the breed of dog, with Jack Russell Terrier or some 'yappy little thing ' proving a favourite.
The winner of the competition was Liverpool-based veterinary surgeon, Anna Rowntree, who won an iPod Nano. She said: "I thought the competition was good fun and a real novelty. It certainly drew me to the stand and was not what I would have expected from the RCVS - it proves they can be approachable! I was very excited to have won and I still can't believe I have."
The noises competition linked to the College's theme for the event, 'Falling on deaf ears?', which examined how the organisation takes account of responses to its consultations, debunking the myth that those who take the trouble to reply are not listened to. The topic was addressed by President Professor Sandy Trees in a presentation on the Saturday of Congress. Visitors to the stand were also given RCVS-branded earphones to reinforce the listening message.
Copies of all three presentations made by the RCVS at BSAVA Congress are now available on RCVSonline (www.rcvs.org.uk/ear_ear). They are:
Royal Canin has launched a new Skin Care family of dermatological diets, designed for the nutritional support of skin function in dogs with dermatosis unrelated to food intolerance or allergy.
At the same time, Royal Canin has also launched DermAlliance, a campaign to improve skin care knowledge in general veterinary practice. The 2011/2012 DermAlliance campaign will include educational initiatives such as free CPD webinars, a training roadshow, case study collaborations and competitions to win skin disease reference materials.
Gudi Stuttard BVSc MRCVS, Royal Canin's Veterinary Support Manager, said: "The Skin Care diets (available for adult dog, adult small dog and junior small dog) offer veterinarians a proven1 option for the nutritional management of dogs with common skin problems.
She added: "The large volume of skin cases we see in general practice necessitates a certain level of expertise in small animal dermatology and we believe our new Skin Care range, coupled with the creation of our dedicated DermAlliance educational campaign, will help promote greater clarity in an often confusing clinical area."
According to Royal Canin, Skin Care diets help in the nutritional management of dogs with reactive skin; they contain a patented complex to help maintain the barrier effect of the skin and high levels of essential fatty acids to help support healthy skin reactions. They also contain a synergistic complex of antioxidants to help support natural defences, and nutrients to help maintain a healthy digestive system and contribute to good oral health.
1 In a multi-centre trial on 47 dogs, the average CADESI (canine atopic dermatitis extent and severity index) score of all dogs improved by a factor of three over three months of being fed Skin Care exclusively. Average CADESI scores increased again after dogs returned to their original diets.